相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reproducing SIVnef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines
James E. Voss et al.
AIDS (2016)
Pulmonary Alveolar Proteinosis Syndrome
Takuji Suzuki et al.
CLINICS IN CHEST MEDICINE (2016)
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses
Matthew Zirui Tay et al.
PLOS PATHOGENS (2016)
Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
Venkateswarlu Chamcha et al.
OPEN FORUM INFECTIOUS DISEASES (2016)
An overview of the HIV epidemic among men who have sex with men in the United Kingdom, 1999-2013
S. Desai et al.
EUROSURVEILLANCE (2015)
Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies
Wilton B. Williams et al.
SCIENCE (2015)
HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition
Heather A. Prentice et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques
Sampa Santra et al.
PLOS PATHOGENS (2015)
The Immune Space: A Concept and Template for Rationalizing Vaccine Development
Amapola Manrique et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2014)
Trends in HIV testing, prevalence among first-time testers, and incidence in most-at-risk populations in Spain: the EPI-VIH Study, 2000 to 2009
M. Diez et al.
EUROSURVEILLANCE (2014)
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Shuying S. Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
Marcella Sarzotti-Kelsoe et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Live Simian Immunodeficiency Virus Vaccine Correlate of Protection: Local Antibody Production and Concentration on the Path of Virus Entry
Qingsheng Li et al.
JOURNAL OF IMMUNOLOGY (2014)
Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles
Paul A. Goepfert et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities
Justin Pollara et al.
JOURNAL OF VIROLOGY (2014)
Analysis of HLA A☆02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial
Andrew J. Gartland et al.
JOURNAL OF VIROLOGY (2014)
Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques
C. Moog et al.
MUCOSAL IMMUNOLOGY (2014)
Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
Amy W. Chung et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Phagocytosis: cell biology view of antiviral function
Ann M. Carias et al.
CURRENT OPINION IN HIV AND AIDS (2014)
Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates
Georgia D. Tomaras et al.
VACCINES (2014)
Non-neutralizing antibodies in prevention of HIV infection
Harriet L. Robinson
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
Hua-Xin Liao et al.
IMMUNITY (2013)
Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect
Julie E. Ledgerwood et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Scott M. Hammer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
Raphael Gottardo et al.
PLOS ONE (2013)
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
Georgia D. Tomaras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells
Christopher A. Todd et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Global epidemiology of HIV infection in men who have sex with men
Chris Beyrer et al.
LANCET (2012)
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144
Merlin L. Robb et al.
LANCET INFECTIOUS DISEASES (2012)
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
Morgane Rolland et al.
NATURE (2012)
Vaccine applications of flow cytometry
Stephen C. De Rosa
METHODS (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine
Michael Hellerstein et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection
Nicole L. Yates et al.
AIDS (2011)
High-Throughput Quantitative Analysis of HIV-1 and SIV-Specific ADCC-Mediating Antibody Responses
Justin Pollara et al.
CYTOMETRY PART A (2011)
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
Morgane Bomsel et al.
IMMUNITY (2011)
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles
Paul A. Goepfert et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Prevention of Infection by a Granulocyte-Macrophage Colony-Stimulating Factor Co-Expressing DNA/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
Lilin Lai et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2h study
Glenda E. Gray et al.
LANCET INFECTIOUS DISEASES (2011)
Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting
Lynn Morris et al.
PLOS ONE (2011)
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
Dennis R. Burton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Development of Two Avidity-Based Assays to Detect Recent HIV Type 1 Seroconversion Using a Multisubtype gp41 Recombinant Protein
Xierong Wei et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
Georgia D. Tomaras et al.
JOURNAL OF VIROLOGY (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination
Helen Horton et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
Punnee Pitisuttithum et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection
Helen Horton et al.
JOURNAL OF VIROLOGY (2006)
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and CHIV-1 primary viruses
Hua-Xin Liao et al.
VIROLOGY (2006)
Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type I group m consensus envelope glycoprotein
F Gao et al.
JOURNAL OF VIROLOGY (2005)
DNA/MVA vaccine for HIV type 1: Effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime
JM Smith et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Multiprotein HIV type 1 clade B DNA and MVA vaccines: Construction, expression, and immunogenicity in rodents of the MVA component
LS Wyatt et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Multiprotein HIV type 1 clade B DNA/MVA vaccine: Construction, safety, and immunogenicity in macaques
JM Smith et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
AIDS - Diversity considerations in HIV-1 vaccine selection
B Gaschen et al.
SCIENCE (2002)
分享论文
